Literature DB >> 16617449

Bronchial responsiveness to methacholine and adenosine 5'-monophosphate in preschool children with bronchopulmonary dysplasia.

Do Kyun Kim1, Sun Hee Choi, Jinho Yu, Young Yoo, Beyong ll Kim, Young Yull Koh.   

Abstract

Bronchial hyperresponsiveness (BHR) is a characteristic feature of asthma, but it is also frequently present in children and adults with chronic obstructive lung diseases. Bronchopulmonary dysplasia (BPD) is a chronic lung disease, most commonly developing after mechanical ventilation and oxygen therapy in premature infants. BHR is usually measured by bronchial challenges, using direct or indirect stimuli. The aim of this study was to evaluate BHR to direct and indirect stimuli in young children with BPD. Methacholine and adenosine 5'-monophosphate (AMP) bronchial challenges were performed on preschool children with BPD (n = 19), using a modified auscultation method. The endpoint was defined as the appearance of wheezing and/or oxygen desaturation. The results obtained were then compared with those of asthmatic (n = 25) and control (n = 23) preschool children. A positive response to methacholine (endpoint concentration, < or = 8 mg/ml) was observed in 89.5% (17/19) of patients with BPD, but a positive response to AMP (endpoint concentration, < or = 200 mg/ml) was observed only in 21.1% (4/19). All patients with asthma responded positively to methacholine, and most (23/25, 92.0%) of them also responded positively to AMP. The majority of controls were unresponsive to both challenges. BHR to methacholine is a frequent finding in preschool-age survivors of BPD, but is usually not accompanied by BHR to AMP. This suggests that most patients with BPD do not have the inflammatory airway response which is characteristic of asthmatic patients. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617449     DOI: 10.1002/ppul.20402

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  4 in total

1.  Longitudinal measures of lung function in infants with bronchopulmonary dysplasia.

Authors:  Amy G Filbrun; Antonia P Popova; Marisa J Linn; Nancy A McIntosh; Marc B Hershenson
Journal:  Pediatr Pulmonol       Date:  2010-11-17

2.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

3.  Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity.

Authors:  Min Yee; Patricia R Chess; Sharon A McGrath-Morrow; Zhengdong Wang; Robert Gelein; Rui Zhou; David A Dean; Robert H Notter; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-17       Impact factor: 5.464

4.  S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia.

Authors:  Thomas M Raffay; Andrew M Dylag; Juliann M Di Fiore; Laura A Smith; Helly J Einisman; Yuejin Li; Mitchell M Lakner; Ahmad M Khalil; Peter M MacFarlane; Richard J Martin; Benjamin Gaston
Journal:  Mol Pharmacol       Date:  2016-08-02       Impact factor: 4.436

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.